Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Milligan-Morgan Hemorrhoidectomy Versus Dearterialization With Mucopexy in the Treatment of Grade III Hemorrhoidal Disease: Multicenter Retrospective Study

NCT04863963 is registered in ClinicalTrials.gov with Università degli Studi dell'Aquila as lead sponsor.

NCT NCT04863963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04863963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Milligan-Morgan Hemorrhoidectomy Versus Dearterialization With Mucopexy in the Treatment of Grade III Hemorrhoidal Disease: Multicenter Retrospective Study
Lead sponsor
Università degli Studi dell'Aquila
Phase
Observational
Overall status
Completed
Start date
July 1, 2021
Completion date
September 25, 2021
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoid prolapse, hemorrhoids